Fundai

Shafa Darou Investment Company (SHAFA) income statement

Operating revenue through to net profit and earnings per share

Ticker
SHAFA
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 9-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/09/30To 1402/09/30To 1401/09/30To 1400/09/30
درآمد سود سهام44,36256,8843,394,56443,56886,23440,266
Other income41600000
Total operating revenue44,77856,8843,394,564721,4051,150,25740,666
هزینه های حقوق، دستمزد و مزایا-399,716-194,930-134,899-222,671-137,237-103,690
Depreciation expense-6,038-6,395-6,531---
Rent expense-8,100-8,100-11,700---
Other expenses-127,109-76,674-127,92600-508
جمع هزینه های عملیاتی-540,963-286,099-281,056-222,671-137,237-104,198
Operating profit (loss)-496,185-229,2153,113,508498,7341,013,020-63,532
Other non-operating income and expenses98,530104,922108,184126,612177,726202
Profit (loss) from continuing operations before tax-397,655-124,2933,221,692625,3461,190,746-63,330
Net profit (loss) from continuing operations-397,655-124,2933,217,933606,6311,151,825-63,330
Net profit (loss)-397,655-124,2933,217,933606,6311,151,825-63,330
Operating (rials)-184-851,152123375-24
Non-operating (rials)363939127510
Arising from continuing operations-148-461,191---
سود (زیان) پایه هر سهم (ریال)-148 rials-46 rials1,191 rials250 rials426 rials-24 rials
سود (زیان) خالص هر سهم (ریال)-146 rials-45 rials1,187 rials224 rials425 rials-23 rials
Capital2,712,0002,712,0002,712,0002,712,0002,712,0002,712,000

Reporting periods

54 periods are on file for this report, from the period ending 1385/12/29 to the period ending 1405/06/31.